---
title: ALS TDI OMOP Data Set
hide:
  - title
---

# ğŸ“¦ Release Notes: Version 0.1.0

The first release of the [ALS TDI ARC Study](https://www.als.net/arc/), mapped to the [Observational Medical Outcomes Partnership Common Data Model (OMOP CDM)](https://ohdsi.github.io/CommonDataModel/), restructures a subset of the ARC Natural HIstory Study into the OMOP CDM structure and maps a subset to standardized vocabularies.

This is part of a larger harmonization effort with [Answer ALS](https://www.answerals.org/) and the [Critical Path Institute](https://c-path.org/program/critical-path-for-rare-neurodegenerative-diseases/).

> **Note about EHR data:** We are actively working to include electronic health record (EHR) data in our next release.  Tools that we use for EHR data and related analytics include:

> - [**CDAtransformer**](https://github.com/BoyceLab/CDAtransformer) â€” This R Shiny application allows users to upload and parse C-CDA and FHIR text files. It extracts relevant elements and presents them in a tabular format for easy viewing and download.  
> - [**RWDExchange**](https://github.com/BoyceLab/RWDExchange) â€” RWDExchange is an R Shiny application designed to evaluate the exchangeability potential of your real-world data (RWD) including electronic health records and patient registries for use as external comparators in clinical trials.

---

---

### ğŸ“ Complete Data Set and Documentation Location  
**[Neuromine Data Portal](https://data.answerals.org/home)**

---

### ğŸ§® CDM Version  
- **OMOP CDM Version 5.4** â€“ [View Documentation](https://ohdsi.github.io/CommonDataModel/cdm54.html)


### ğŸ‘¥ Participant Summary  
- **Total number of participants**: 1,676  
  > *Note: not all participants answered all surveys*

The dataset contains data from the following participant types:
- People with ALS
- Asymptomatic carriers
- Healthy controls  

> Participant type can be found in the **Person** table, under the participant_source column.

This version of the ALS TDI dataset includes:
- Self-reported surveys and ALSFRS-R (ALS Functional Rating Scale â€“ Revised) data
- Laboratory results from analyzed blood samples

---

### ğŸ“š Citation

> **ALS Therapy Development Institute (ALS TDI). (2023).**  *ALS Research Collaborative (ARC) [Data set].*  Amyotrophic Lateral Sclerosis Therapy Development Institute.   https://doi.org/10.71944/C3NA-9124

---

## ğŸ§© Mappings

- **ğŸ§ Person**:  
  Demographics including year of birth, sex, race, and ethnicity.  
  See accepted concepts [here](https://ohdsi.github.io/CommonDataModel/cdm54.html).

- **ğŸ—’ï¸ Observation**:  
  - ALSFRS-R (individual items and total score)  
  - Family and personal medical history  
  - Site of onset  
  - Injury history  
  - Military service  
  - Tobacco use

- **ğŸ’Š Drug Exposure**:  
  Medications and select supplements

- **âš°ï¸ Mortality**:  
  Date of death

- **ğŸ§ª Measurement**:  
  - Laboratory data from blood draws  
  - Self-reported genetic mutations

- **ğŸ“Œ Other Variables**:  
  - Military service  
  - Industry of employment  
  - Injury history

---

## ğŸ“Œ Notes on Mapping Decisions

### ğŸ—“ï¸ Dates and Timing

Dates may be shifted for deidentification purposes using the method described in:

> Hripcsak G, Mirhaji P, Low AF, Malin BA.  *Preserving temporal relations in clinical data while maintaining privacy.*  J Am Med Inform Assoc. 2016 Nov;23(6):1040-1045.  
> [Link to publication](https://doi.org/10.1093/jamia/ocw001)  

In the **Observation Period** OMOP domain:
- observation_period_start_date = first event date (usually first survey)  
- observation_period_end_date = last event date or date of death

---

### â“ Missing Data

If a data point was not collected, it is excluded unless required by OMOP CDM.  
See the "Required" column in the [CDM v5.4 guidance](https://ohdsi.github.io/CommonDataModel/cdm54.html)

**Examples:**
- If **ethnicity** is unknown â†’ concept_id = 0  
- If **race** is unknown or multiple â†’ concept_id = 0

---

### ğŸ› ï¸ Custom Concepts
> **What are custom concepts?**  
In the OMOP Common Data Model, most clinical information is standardized using concept IDs from shared vocabularies (like SNOMED, RxNorm, LOINC, etc.). However, sometimes source data includes important information that **doesnâ€™t have an existing standardized concept** in these vocabularies.

In those cases, researchers define **custom (or local) concepts** with unique concept IDs (usually starting above 2,000,000,000). These custom concepts allow valuable variables â€” such as ALS symptom onset patterns, survey-specific fields, or patient-reported values â€” to be included in the dataset in a structured, queryable way.

In the ALS TDI OMOP data set, custom concepts were created for:
- **ALS symptom onset**
- **Anatomical site of symptom onset**
- Additional variables unique to the ARC study

> These custom concepts are stored and referenced just like standard concepts, allowing them to be queried and analyzed using the same OMOP framework.


---

### ğŸ’Š Medications

- Mapped to **ingredient level** wherever possible  
- **Dose not calculated**  
- **All source values retained**  
- If the drug or supplement was **unmapped**:
  - concept_id = 0
  - Source data included in the appropriate source column

---

## ğŸ§­ Guidance for Using This Data Set

- ğŸ” **Review the *_source_value or *_source_concept_id columns** in each OMOP table to understand how data were originally captured. These often contain verbatim responses or terms from the source survey.

- ğŸ§  **Explore concept definitions** and standardized codes using the [OHDSI Athena](https://athena.ohdsi.org/) tool. You can look up concept IDs used throughout the dataset and understand their relationships and domains.
